One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-136265
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 5 |
Affiliation: Osaka University, Sumitomo Hospital, Roche (Germany), Roche (Switzerland), Tokyo Medical University, Agostino Gemelli University Polyclinic, Università Cattolica del Sacro Cuore, Atlas Copco (United States), Essen University Hospital, Osaka University Hospital, Immungenetics (Germany), University of Ulm, RWTH Aachen University, Hôpital Fernand-Widal, Yonsei University, Severance Hospital, Seoul National University Hospital, University of California, San Francisco
An Optimized Crovalimab Dose and Regimen Reduced the Formation of Drug-Target-Drug Complexes in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Phase I/II COMPOSER Trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
